Débora Sartori Giaretta, Helena Dai Prá Maestri, Pedro Henrique Zanella Catto, Alessandra Dalla Rosa Santini, Moacir Alexandre Traesel, Florência Ferreira Barreiro, Luísa Litvin Raffin, Carlos Eduardo Poli-de-Figueiredo, Leonardo Viliano Kroth
{"title":"Kidney Transplantation: A Review of 45 Years of a Southern Brazilian Hospital","authors":"Débora Sartori Giaretta, Helena Dai Prá Maestri, Pedro Henrique Zanella Catto, Alessandra Dalla Rosa Santini, Moacir Alexandre Traesel, Florência Ferreira Barreiro, Luísa Litvin Raffin, Carlos Eduardo Poli-de-Figueiredo, Leonardo Viliano Kroth","doi":"10.1016/j.transproceed.2026.05.008","DOIUrl":null,"url":null,"abstract":"<div><div>Kidney transplantation is the best therapeutic option for patients with end-stage kidney disease, providing longer survival and quality of life. This retrospective single-center study analyzed all kidney transplants performed at Hospital São Lucas da PUCRS between 1978 and 2023, categorizing patients into different eras according to the evolution of immunosuppressive protocols. A total of 1,920 transplants were performed, and patient survival at 1, 3, and 5 years was evaluated, which was estimated at 89.6%, 86%, and 82.8%, respectively, for living donors and 85%, 80.3%, and 76.2%, respectively, for deceased donors. The acute rejection rate decreased from 39.2% in the years 1987 to 1997 to 18.8% in the most recent era. The impact of the COVID-19 pandemic was significant, increasing mortality and temporarily reducing the transplant rate. The findings demonstrate improvements in patient and graft survival over the years, in line with advances in surgical and immunosuppressive techniques. However, challenges such as infections and chronic complications remain relevant. Future studies should focus on optimizing clinical management and mitigating the impacts of health crises on the transplant population.</div></div>","PeriodicalId":23246,"journal":{"name":"Transplantation proceedings","volume":"58 7","pages":"Pages 1253-1262"},"PeriodicalIF":0.8000,"publicationDate":"2026-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Transplantation proceedings","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0041134526002459","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/6/11 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Kidney transplantation is the best therapeutic option for patients with end-stage kidney disease, providing longer survival and quality of life. This retrospective single-center study analyzed all kidney transplants performed at Hospital São Lucas da PUCRS between 1978 and 2023, categorizing patients into different eras according to the evolution of immunosuppressive protocols. A total of 1,920 transplants were performed, and patient survival at 1, 3, and 5 years was evaluated, which was estimated at 89.6%, 86%, and 82.8%, respectively, for living donors and 85%, 80.3%, and 76.2%, respectively, for deceased donors. The acute rejection rate decreased from 39.2% in the years 1987 to 1997 to 18.8% in the most recent era. The impact of the COVID-19 pandemic was significant, increasing mortality and temporarily reducing the transplant rate. The findings demonstrate improvements in patient and graft survival over the years, in line with advances in surgical and immunosuppressive techniques. However, challenges such as infections and chronic complications remain relevant. Future studies should focus on optimizing clinical management and mitigating the impacts of health crises on the transplant population.
肾移植是终末期肾病患者的最佳治疗选择,可提供更长的生存期和生活质量。这项回顾性单中心研究分析了1978年至2023年期间在 o Lucas da PUCRS医院进行的所有肾移植手术,根据免疫抑制方案的发展将患者分为不同的时代。总共进行了1920例移植,并评估了患者在1年、3年和5年的生存率,活体供者的生存率分别为89.6%、86%和82.8%,死亡供者的生存率分别为85%、80.3%和76.2%。急性排异率由1987 ~ 1997年的39.2%下降到最近的18.8%。COVID-19大流行的影响是显著的,死亡率增加,移植率暂时降低。研究结果表明,随着手术和免疫抑制技术的进步,多年来患者和移植物的存活率有所提高。然而,感染和慢性并发症等挑战仍然存在。未来的研究应侧重于优化临床管理和减轻健康危机对移植人群的影响。
期刊介绍:
Transplantation Proceedings publishes several different categories of manuscripts, all of which undergo extensive peer review by recognized authorities in the field prior to their acceptance for publication.
The first type of manuscripts consists of sets of papers providing an in-depth expression of the current state of the art in various rapidly developing components of world transplantation biology and medicine. These manuscripts emanate from congresses of the affiliated transplantation societies, from Symposia sponsored by the Societies, as well as special Conferences and Workshops covering related topics.
Transplantation Proceedings also publishes several special sections including publication of Clinical Transplantation Proceedings, being rapid original contributions of preclinical and clinical experiences. These manuscripts undergo review by members of the Editorial Board.
Original basic or clinical science articles, clinical trials and case studies can be submitted to the journal?s open access companion title Transplantation Reports.